PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHDBradley M. Haverkos, Steven M. Devine, Yi‐Bin Chen et al.|Blood|2017Cited by 247
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in OncologySteven M. Horwitz, Hema Sundar, Stephen M. Ansell et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 172
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020Neha Mehta–Shah, Youn H. Kim, Sarah McCue Horwitz et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 121
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018Steven M. Horwitz, Hema Sundar, Stephen M. Ansell et al.|Journal of the National Comprehensive Cancer Network|2018Cited by 79
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021Steven M. Horwitz, Hema Sundar, Stephen M. Ansell et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 62